A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Primary Research, Independent Perspective, & Objective Analysis
Latest Reports Latest NewsLatest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 350
Comprehensive Pages
- 40
Competitor Profiles
- 11
IOL Categories Forecasted
- 8
Geographic/Economic Breakouts
2022 IOL Market Report: Global Analysis for 2021 to 2027, April, 2022
The “2022 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs.
Latest Industry News & Trends
6/24/2022
BreakingChinaPharmaRegulationRetina
EyePoint and OcuMension Announce Yutiq’s Approval for Uveitis in China
EyePoint Pharmaceuticals and OcuMension Therapeutics announced June 21 that China regulators had approved Yutiq (fluocinolone acetonide intravitreal implant) 0.18 mg for the treatment of chronic no...
6/24/2022
BreakingDealsRetina
Apellis Plans IND with Partner Affilogic for C3 Inhibitor in Wet AMD and GA
Apellis Pharmaceuticals announced June 22 that it and partner Affilogic, of France, plan to submit an investigational new drug (IND) application to the US FDA within the next 12 months for APL-2006...
6/24/2022
BreakingPharmaRegulation
Medicare Could Have Saved $3.6B Paying Same Drug Prices as Those at Mark Cuban Pharmacy
Medicare could have saved $3.6 billion in 2020 by purchasing generic drugs at the prices offered by Cost Plus Drug Company, the online pharmacy of Mark Cuban, according to research published June 2...
6/24/2022
BreakingRetinaStudy
Researchers Revive Photoreceptors in Organ Donor Eyes
Researchers at the University of Utah John A. Moran Eye Center have revived photoreceptors in organ donor eyes and restored communication between them, according to research published in May in the...
6/24/2022
BreakingRetinaStudy
Researchers Create ‘Self-Plugging’ Microneedle for IVT Drug Delivery
Researchers say they’ve developed a “self-plugging” microneedle to deliver drugs to the eye that will reduce some of the risks of intravitreal injection with hypodermic needles, according to work p...
6/24/2022
BreakingClinical TrialDry EyeRegulation
Aldeyra Announces Positive Phase III Results for Reproxalap in Dry Eye
Aldeyra Therapeutics, of Lexington, Massachusetts, reported June 8 that its Phase III TRANQUILITY-2 trial for dry eye candidate reproxalap met its primary endpoints. Reproxalap was statistically su...
6/24/2022
BreakingIndustryRetina
Foundation Fight Blindness Names Jason Menzo as CEO, Russell Kelley as Head of RD Fund
The Foundation Fighting Blindness reported June 21 that it had promoted Jason Menzo to chief executive officer (CEO) and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration F...
6/24/2022
BreakingGene TherapyIndustry
Opus Genetics Appoints Ben Yerxa, PhD, as Permanent CEO
Opus Genetics announced June 21 thatBen Yerxa, PhD, would become permanent chief executive officer after serving as acting CEO. Yerxa will leave his other positions as CEO of Foundation Fighting Bl...
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayMarket Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Over 500 Clients, Large & Small, Have Trusted Market Scope Data & Analysis
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.